Drug Shortage Report for LATANOPROST AND TIMOLOL OPHTHALMIC SOLUTION
Report ID | 193838 |
Drug Identification Number | 02489368 |
Brand name | LATANOPROST AND TIMOLOL OPHTHALMIC SOLUTION |
Common or Proper name | LATANOPROST AND TIMOLOL OPHTHALMIC SOLUTION |
Company Name | HIKMA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | TIMOLOL LATANOPROST |
Strength(s) | 5MG 50MCG |
Dosage form(s) | SOLUTION |
Route of administration | OPHTHALMIC |
Packaging size | 2.5mL |
ATC code | S01ED |
ATC description | ANTIGLAUCOMA PREPARATIONS AND MIOTICS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | 2023-06-26 |
Actual start date | |
Estimated end date | |
Actual end date | 2024-10-01 |
Shortage status | Resolved |
Updated date | 2024-10-03 |
Company comments | Product to be discontinued. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 5995 AVEBURY ROAD, SUITE 804 MISSISSAUGA, ONTARIO CANADA L5R 3P9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v9 | 2024-10-03 | French | Compare |
v8 | 2024-10-03 | English | Compare |
v7 | 2024-10-02 | English | Compare |
v6 | 2024-10-01 | French | Compare |
v5 | 2024-10-01 | English | Compare |
v4 | 2023-06-27 | English | Compare |
v3 | 2023-06-06 | French | Compare |
v2 | 2023-06-06 | English | Compare |
v1 | 2023-06-06 | English | Compare |
Showing 1 to 9 of 9